Pharmaceuticals · Key players

Top CAR-T Cell Therapy companies

The 6 key players our CAR-T Cell Therapy report profiles, and other companies free public records show in this market.

Key players in CAR-T Cell Therapy

In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.

Key players in the CAR-T Cell Therapy market
#CompanyWebsiteOur reports
1 Gilead Sciences, Inc. gilead.com (opens in a new tab) 297 reports
2 Novartis AG novartis.com (opens in a new tab) 1,551 reports
3 Bristol-Myers Squibb bms.com (opens in a new tab) 627 reports
4 Johnson & Johnson jnj.com (opens in a new tab) 2,376 reports
5 Legend Biotech — 33 reports
6 Autolus Therapeutics — 33 reports

Also active in CAR-T Cell Therapy

Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.

Also active in CAR-T Cell Therapy, from free public records
CompanyWhere public records show them
Chongqing Precision Biotech Co., Ltd
Fresenius SE & CO
Roche
AstraZeneca
Celltrion
Seattle Genetics
Biogen Inc
Hebei Senlang Biotechnology Inc., Ltd.
Miltenyi Biomedicine GmbH
Beijing Immunochina Medical Science & Technology Co., Ltd.
Fate Therapeutics
Nanjing IASO Biotechnology Co., Ltd.

Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

Source: Drugs@FDA, US approvals each company holds for medicines on the market whose FDA label lists this use. Retrieved 13 Nov 2026.

Top trial sponsors in CAR-T Cell Therapy

Companies leading the most active studies found with this market's trial search, worldwide (key players included).

  1. Chongqing Precision Biotech Co., Ltd 25 active trials on ClinicalTrials.gov (opens in a new tab)
  2. Bristol-Myers Squibb 13 active trials on ClinicalTrials.gov (opens in a new tab)
  3. AstraZeneca 12 active trials on ClinicalTrials.gov (opens in a new tab)
  4. Novartis AG 11 active trials on ClinicalTrials.gov (opens in a new tab)
  5. Hebei Senlang Biotechnology Inc., Ltd. 9 active trials on ClinicalTrials.gov (opens in a new tab)
  6. Miltenyi Biomedicine GmbH 8 active trials on ClinicalTrials.gov (opens in a new tab)
  7. Beijing Immunochina Medical Science & Technology Co., Ltd. 7 active trials on ClinicalTrials.gov (opens in a new tab)
  8. Fate Therapeutics 6 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

CAR-T Cell Therapy reports by place

All 33 places for CAR-T Cell Therapy

Get the full CAR-T Cell Therapy report

Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.

Buy the full report Request free sample

Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.